Vrm Molecular And Nuclear Medicines Private Limited - Company Profile

It is a healthcare private limited company based in Indore, Madhya Pradesh, India, established in 1996.
1996 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Vrm Molecular And Nuclear Medicines Private Limited

Vrm Molecular And Nuclear Medicines Private Limited, a active private limited company, was established on 05 February 1996 in Indore, Madhya Pradesh, India. Engaging in preventive health services within the financial and insurance service sector, it holds CIN: U21002MP1996PTC010463. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.45 M.

It upholds a compliant status. Its leadership includes Mohd Daud (Director), Purushottam Das Vaishya (Director), Manjushree Bhandari (Director). Past directors included Vinod Kumar Bhandari, Purushottam Das Vaishya, Danish Suleman. It holds ₹50.05 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 21-G,F-Scheme No.54, Opp.Meghdoot Garden, Indore, Madhya Pradesh.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002MP1996PTC010463

  • Registration Number

    010463

  • Incorporation Date

    05 February 1996

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.45 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.45 M
  • Company Age 30 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 50.05 Cr
  • Revenue Growth **** %
  • Profit Growth **** 2.42%
  • Ebitda **** -13.52%
  • Net Worth -0.50%
  • Total Assets -0.01%
Company report

Vrm Molecular And Nuclear Medicines Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vrm Molecular And Nuclear Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vrm Molecular And Nuclear Medicines Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohd Daud Director 01 Dec 2025 Current
Purushottam Das Vaishya Director 13 Jun 2024 Current
Manjushree Bhandari Director 05 Feb 1996 Current
Mohit Bhandari Director 12 Aug 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Sep 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 30 Sep 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vrm Molecular And Nuclear Medicines.

Vrm Health Wizard India Insurance Broking Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.42% increase in profit. The company's net worth dipped by a decrease of 0.5%.

Vrm Molecular And Nuclear Medicines revenue growth over time
Vrm Molecular And Nuclear Medicines profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.01%
*******
*******
*******
*******
Profit or Loss
*******
 2.42%
*******
*******
*******
*******
Net Worth
*******
 -0.50%
*******
*******
*******
*******
EBITDA
*******
 -13.52%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vrm Molecular And Nuclear Medicines?

Unlock access to Vrm Molecular And Nuclear Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹500,525,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 50.05 Cr
Latest Charge Details
Date Lender Amount Status
09 Jul 2025 Hdfc Bank Limited ₹50.05 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Vrm Molecular And Nuclear Medicines?

Unlock and access historical data on people associated with Vrm Molecular And Nuclear Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vrm Molecular And Nuclear Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vrm Molecular And Nuclear Medicines's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vrm Molecular And Nuclear Medicines
Recent Activity within the Organization
  • Director Appointment

    Mohd Daud was appointed as a Director was appointed as a Director on 01 Dec 2025 & has been associated with this company since 3 months 7 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Vrm Molecular And Nuclear Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 500.53 M registered on 09 Jul 2025 with Charge ID 101141758 was modified on 01 Sep 2025. was recorded as a recent event.

  • Director Appointment

    Progress on Danish Suleman was appointed as a Ceo was appointed as a Ceo on 28 Aug 2025 & has been associated with this company since 6 months 11 days . was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 500.53 M with Charge ID 101141758 was registered on 09 Jul 2025. was documented.

  • Balance Sheet

    Vrm Molecular And Nuclear Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vrm Molecular And Nuclear Medicines Private Limited?

The CIN of Vrm Molecular And Nuclear Medicines Private Limited is U21002MP1996PTC010463.

Where is Vrm Molecular And Nuclear Medicines Private Limited headquartered?

Vrm Molecular And Nuclear Medicines Private Limited is headquartered at 21-G,F-Scheme No.54, Opp.Meghdoot Garden, Indore, Madhya Pradesh.

When was Vrm Molecular And Nuclear Medicines Private Limited incorporated?

Vrm Molecular And Nuclear Medicines Private Limited was incorporated on 05 February 1996.

Who are the current directors of Vrm Molecular And Nuclear Medicines Private Limited?

The current directors of Vrm Molecular And Nuclear Medicines Private Limited are

What is the primary industry of Vrm Molecular And Nuclear Medicines Private Limited?

The primary industry of Vrm Molecular And Nuclear Medicines Private Limited is Financial And Insurance Service.

Is Vrm Molecular And Nuclear Medicines Private Limited a listed company?

Vrm Molecular And Nuclear Medicines Private Limited is unlisted.

What is the capital structure of Vrm Molecular And Nuclear Medicines Private Limited?

The authorized capital of Vrm Molecular And Nuclear Medicines Private Limited is ₹0.50 M, and the paid-up capital is ₹0.45 M.

What is the compliance status of Vrm Molecular And Nuclear Medicines Private Limited?

The compliance status of Vrm Molecular And Nuclear Medicines Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available